Indefinite Delivery Contract VA24416D0141

The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sun Pharmaceutical Industries, Inc. with a potential value of $8 million. The BPA is for the delivery of radiopharmaceutical dose products and consumables to support nuclear medicine services through January 2025. No set-asides were applied to this procurement. The original solicitation sought a contractor to provide radiopharmaceuticals and related supplies necessary for diagnostic imaging and therapeutic...

The Department of the Army Medical Command awarded a $1 million blanket purchase agreement to Pharmalucence, Inc. to provide various radiopharmaceuticals to military treatment facilities. No set-aside was designated for this single award contract, which has a period of performance from October 1, 2020 through September 30, 2025. Three task orders were subsequently awarded against this blanket purchase agreement by the Defense Health Agency to procure radiopharmaceuticals and related supplies...

The Department of Veterans Affairs Veterans Health Administration awarded a single-award, firm-fixed price indefinite-delivery/indefinite-quantity contract with a potential value of $3,888,886.25 to Schaaf Drugs, LLC doing business as Heartlight Pharmacy Services to provide radiopharmaceutical products and delivery services in support of nuclear medicine procedures at the Dayton VA Medical Center in Lima, Ohio. The base period of performance is from October 1, 2021 through September 30, 2026,...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded an indefinite delivery contract to Pharmalogic WV LTD for the delivery of radiopharmaceutical products and services in support of nuclear medicine programs serving veterans. The base contract value is $388,738.36 for the period of October 1, 2020 through March 31, 2024. Four task orders were subsequently issued against the contract with values ranging from $265,884.10 to $900,000.00...

The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) contract to Telix Pharmaceuticals US Inc. for the provision of various radiopharmaceuticals. The single-award BPA has a ceiling value of $4,498,000.00 and a period of performance from October 1, 2023 through September 30, 2028. Under this BPA, the VA VHA has issued a $910,000.00 firm fixed price BPA Call Order to Telix Pharmaceuticals US Inc. for the base period from...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 (VA - VHA) awarded a single-award, firm fixed price Indefinite Delivery Indefinite Quantity (IDIQ) contract to Cardinal Health 414, LLC Nphs Division for radiopharmaceuticals. The contract has a potential value of $744,455.20 and a one-year period of performance from October 1, 2022 through September 30, 2023. The contract aims to procure various radiopharmaceuticals for use at the VA...

The U.S. Department of Veterans Affairs (VA) Veterans Health Administration has awarded a single-award indefinite delivery contract to Pharmalogic Syracuse, LLC, a for-profit limited liability company, to provide radiopharmaceuticals to the Albany VA Medical Center Nuclear Medicine department. The contract has a ceiling value of $3,800,294.96 and covers a base year plus four option years from April 1, 2024 through March 31, 2029. Pharmalogic Syracuse, LLC will be required to provide a wide...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA-VHA) awarded a blanket purchase agreement to Jubilant Draximage Radiopharmacies, Inc. doing business as Jubilant Radiopharma for the provision of radiopharmaceutical supplies. Under the single award agreement, which has a potential value of $1,379,724.67 and expires on March 31, 2028, the contractor may receive delivery orders for radiopharmaceuticals through April 30, 2024. The first...

This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the delivery of non-positron emission tomography (non-PET) radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. The contract has a performance period from April 1, 2025, to March 31, 2026, with a ceiling value of $425,725.07. RLS (USA) Inc. is an experienced...

The Defense Health Agency awarded RLS USA Inc. a single award indefinite delivery contract for radiopharmaceuticals with a potential value of $1,914,116.40 over five years. No set-aside provisions were applied. Under this vehicle, RLS USA Inc. received a firm fixed price delivery order for $299,975.67 to supply unspecified radiopharmaceutical products to the Defense Health Agency from their Tampa, Florida facility between November 2022 through September 2023. Additionally, a $64,238.93 order...